: Philips shares slump as FDA says sleep product may overheat

Phillips shares fell sharply Wednesday as the Food and Drug Administration said there’s an emerging safety issue involving its product for sleep apnea.

Previous post The Moneyist: My father has dementia and ‘forgave’ my brother’s $200,000 house loan. The nursing-home notary said he was of sound mind. What can we do?
Next post Foot Locker shares rise as retailer posts earnings beat, gives more upbeat sales outlook